The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease. (Q48432793)

11 February 2018

title

The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease. (English)

1 reference

11 February 2018

1 reference

Matthew J Betts

3

0 references

Arturo Cardenas-Blanco

object named as

Arturo Cardenas-Blanco

2

0 references

Julio Acosta-Cabronero

object named as

Julio Acosta-Cabronero

1

0 references

Peter J Nestor

object named as

Peter J Nestor

7

0 references

author name string

Michaela Butryn

4

1 reference

11 February 2018

Jose P Valdes-Herrera

5

1 reference

11 February 2018

Imke Galazky

6

1 reference

11 February 2018

language of work or name

English

0 references

publication date

11 November 2016

1 reference

11 February 2018

published in

Brain

1 reference

11 February 2018

volume

140

1 reference

11 February 2018

page(s)

118-131

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

In Vivo MRI Mapping of Brain Iron Deposition across the Adult Lifespan

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Cerebellar networks with the cerebral cortex and basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Copper pathology in vulnerable brain regions in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Serum cholesterol and nigrostriatal R2* values in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Ageing and Parkinson's disease: substantia nigra regional selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Generalized autocalibrating partially parallel acquisitions (GRAPPA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

The effect of age on the non-haemin iron in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Iron and dopamine: a toxic couple.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Considerations for measuring iron in post-mortem tissue of Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Dentate nucleus iron deposition is a potential biomarker for tremor-dominant Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Serum uric acid and nigral iron deposition in Parkinson's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

101 labeled brain images and a consistent human cortical labeling protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Assessment of trace elements in human brain using inductively coupled plasma mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Individual dopaminergic neurons show raised iron levels in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Longitudinal changes in free-water within the substantia nigra of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

A Bayesian model of shape and appearance for subcortical brain segmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Comparative reliability of total intracranial volume estimation methods and the influence of atrophy in a longitudinal semantic dementia cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Free-water imaging in Parkinson's disease and atypical parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Mapping metals in Parkinson's and normal brain using rapid-scanning x-ray fluorescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Fast phase unwrapping algorithm for interferometric applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Selective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Adaptive reconstruction of phased array MR imagery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

The role of iron in brain ageing and neurodegenerative disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Permutation inference for the general linear model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

The cerebellum in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWW278

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWW278

1 reference

11 February 2018

PubMed ID

27836833

1 reference

11 February 2018